These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10838604)

  • 1. Anandamide and the question of its functional role for activation of capsaicin receptors.
    Szolcsányi J
    Trends Pharmacol Sci; 2000 Jun; 21(6):203-4. PubMed ID: 10838604
    [No Abstract]   [Full Text] [Related]  

  • 2. Anandamide--a new look on fatty acid ethanolamides.
    Berdyshev EV; Boichot E; Lagente V
    J Lipid Mediat Cell Signal; 1996 Dec; 15(1):49-67. PubMed ID: 9029374
    [No Abstract]   [Full Text] [Related]  

  • 3. Anandamide may mediate sleep induction.
    Mechoulam R; Fride E; Hanus L; Sheskin T; Bisogno T; Di Marzo V; Bayewitch M; Vogel Z
    Nature; 1997 Sep; 389(6646):25-6. PubMed ID: 9288961
    [No Abstract]   [Full Text] [Related]  

  • 4. Anandamide: an endogenous activator of the vanilloid receptor.
    Smart D; Jerman JC
    Trends Pharmacol Sci; 2000 Apr; 21(4):134. PubMed ID: 10740287
    [No Abstract]   [Full Text] [Related]  

  • 5. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N; Bukoski RD
    J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
    Mechoulam R
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
    Smart D; Gunthorpe MJ; Jerman JC; Nasir S; Gray J; Muir AI; Chambers JK; Randall AD; Davis JB
    Br J Pharmacol; 2000 Jan; 129(2):227-30. PubMed ID: 10694225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anandamide serves two masters in the brain.
    Di Marzo V
    Nat Neurosci; 2010 Dec; 13(12):1446-8. PubMed ID: 21102567
    [No Abstract]   [Full Text] [Related]  

  • 9. The anandamide transport inhibitor AM404 activates vanilloid receptors.
    Zygmunt PM; Chuang H; Movahed P; Julius D; Högestätt ED
    Eur J Pharmacol; 2000 May; 396(1):39-42. PubMed ID: 10822052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
    Navarro M; Rodríguez de Fonseca F
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172
    [No Abstract]   [Full Text] [Related]  

  • 11. The gastrointestinal pharmacology of cannabinoids.
    Izzo AA; Mascolo N; Capasso F
    Curr Opin Pharmacol; 2001 Dec; 1(6):597-603. PubMed ID: 11757815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
    Malinowska B; Kwolek G; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
    Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
    J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of nonadrenergic noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum.
    Vural IM; Ozturk GS; Sarioglu Y
    J Sex Med; 2009 Mar; 6(3):717-29. PubMed ID: 19175867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J; Urban L; Bevan S; Nagy I
    Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide - the other side of the coin.
    Zygmunt PM; Julius I; Di Marzo I; Högestätt ED
    Trends Pharmacol Sci; 2000 Feb; 21(2):43-4. PubMed ID: 10664604
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
    Roberts LA; Christie MJ; Connor M
    Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.